Evidence for angiogenesis in Parkinson’s disease, incidental Lewy body disease, and progressive supranuclear palsy
暂无分享,去创建一个
Julie A. Schneider | P. Carvey | Paul M. Carvey | B. Hendey | Brinda Desai Bradaric | Aditiben Patel | Bill Hendey | J. Schneider | Brinda Desai Bradaric | Aditiben Patel | J. Schneider
[1] E Bertrand,et al. Qualitative and quantitative analysis of locus coeruleus neurons in Parkinson's disease. , 1997, Folia neuropathologica.
[2] G. Lynch,et al. Integrin Subunit Gene Expression Is Regionally Differentiated in Adult Brain , 1999, The Journal of Neuroscience.
[3] R. Sidman,et al. Treatment of hypoxia‐induced retinopathy with targeted proapoptotic peptidomimetic in a mouse model of disease , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[4] M. Horton. Vitronectin receptor: tissue specific expression or adaptation to culture? , 1990, International journal of experimental pathology.
[5] P. Rakic,et al. Three‐dimensional counting: An accurate and direct method to estimate numbers of cells in sectioned material , 1988, The Journal of comparative neurology.
[6] Houeto Jean-Luc. [Parkinson's disease]. , 2022, La Revue du praticien.
[7] Belinda Wilson,et al. Aggregated α‐synuclein activates microglia: a process leading to disease progression in Parkinson's disease , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[8] Masanori Ichise,et al. In vivo imaging of microglial activation using a peripheral benzodiazepine ligand, 11C-CB148 and animal PET following ethanol injury in rat striatum: A comparison with 11C-PK11195 , 2007 .
[9] A. Vagnucci,et al. For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group. Alzheimer's Disease and Angiogenesis , 2022 .
[10] A. Rajput,et al. Accuracy of Clinical Diagnosis in Parkinsonism — A Prospective Study , 1991, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[11] M. Matsunaga,et al. Effects of benserazide on l-DOPA-derived extracellular dopamine levels and aromatic l-amino acid decarboxylase activity in the striatum of 6-hydroxydopamine-lesioned rats , 2003 .
[12] I. Campbell,et al. The Extracellular Matrix and Cytokines Regulate Microglial Integrin Expression and Activation1 , 2003, The Journal of Immunology.
[13] Y. Michotte,et al. Benserazide decreases central AADC activity, extracellular dopamine levels and levodopa decarboxylation in striatum of the rat , 2001, Journal of Neural Transmission.
[14] W. Streit. Microglial senescence: does the brain's immune system have an expiration date? , 2006, Trends in Neurosciences.
[15] N. Hattori,et al. Correlation between levels of pigment epithelium-derived factor and vascular endothelial growth factor in the striatum of patients with Parkinson's disease , 2007, Experimental Neurology.
[16] D. Dione,et al. Targeted imaging of hypoxia-induced integrin activation in myocardium early after infarction. , 2008, Journal of applied physiology.
[17] D. Cheresh,et al. Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. , 1994, Cell.
[18] Max Gassmann,et al. Astrocyte responses to injury: VEGF simultaneously modulates cell death and proliferation. , 2008, American journal of physiology. Regulatory, integrative and comparative physiology.
[19] S. Dedhar,et al. Immunohistochemical localization of vitronectin, its receptor and beta-3 integrin in Alzheimer brain tissue , 1991, Journal of Neuroimmunology.
[20] I Litvan,et al. Preliminary NINDS neuropathologic criteria for Steele‐Richardson‐Olszewski syndrome (progressive supranuclear palsy) , 1994, Neurology.
[21] D. Dickson,et al. Microglial Activation Parallels System Degeneration in Progressive Supranuclear Palsy and Corticobasal Degeneration , 2001, Journal of neuropathology and experimental neurology.
[22] Y. Mizuno,et al. Expression levels of vascular endothelial growth factor and its receptors in Parkinson's disease , 2006, Neuroreport.
[23] H. Braak,et al. Neuroanatomy and pathology of sporadic Parkinson's disease. , 2008, Advances in anatomy, embryology, and cell biology.
[24] Ling Wei,et al. Collateral Growth and Angiogenesis Around Cortical Stroke , 2001, Stroke.
[25] Sanjiv S Gambhir,et al. Dual-targeted contrast agent for US assessment of tumor angiogenesis in vivo. , 2008, Radiology.
[26] D. Dickson,et al. Diagnostic accuracy of progressive supranuclear palsy in the Society for Progressive Supranuclear Palsy Brain Bank , 2003, Movement disorders : official journal of the Movement Disorder Society.
[27] J. Nyengaard,et al. Endothelial Proliferation and Increased Blood–Brain Barrier Permeability in the Basal Ganglia in a Rat Model of 3,4-Dihydroxyphenyl-l-Alanine-Induced Dyskinesia , 2006, The Journal of Neuroscience.
[28] H. Gendelman,et al. Nitrated α–Synuclein Immunity Accelerates Degeneration of Nigral Dopaminergic Neurons , 2008, PloS one.
[29] Ivan Damjanov,et al. Blood Vessels , 2004 .
[30] D. Bennett,et al. LONG-TERM FETAL CELL TRANSPLANT IN HUNTINGTON DISEASE: STAYIN’ ALIVE , 2007, Neurology.
[31] Alexander Gerhard,et al. In vivo imaging of microglial activation with [11C](R)‐PK11195 PET in progressive supranuclear palsy , 2006, Movement disorders : official journal of the Movement Disorder Society.
[32] J. Schneider,et al. Neuropathology of older persons without cognitive impairment from two community-based studies , 2006, Neurology.
[33] F. Carraro,et al. Role of inflammatory mediators in angiogenesis. , 2005, Current drug targets. Inflammation and allergy.
[34] J. Kordower,et al. Age and region‐specific responses of microglia, but not astrocytes, suggest a role in selective vulnerability of dopamine neurons after 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine exposure in monkeys , 2008, Glia.
[35] David A. Bennett,et al. Decision Rules Guiding the Clinical Diagnosis of Alzheimer’s Disease in Two Community-Based Cohort Studies Compared to Standard Practice in a Clinic-Based Cohort Study , 2006, Neuroepidemiology.
[36] E. Hirsch,et al. Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease. , 2008, The Journal of clinical investigation.
[37] B. Jin,et al. The role of neuroinflammation on the pathogenesis of Parkinson's disease. , 2010, BMB reports.
[38] P. Mcgeer,et al. Glial reactions in Parkinson's disease , 2008, Movement disorders : official journal of the Movement Disorder Society.
[39] M. Graeber,et al. Controversies over the staging of α-synuclein pathology in Parkinson’s disease , 2008, Acta Neuropathologica.
[40] P. Carvey,et al. Evidence of angiogenic vessels in Alzheimer’s disease , 2009, Journal of Neural Transmission.
[41] D. Cheresh,et al. Definition of two angiogenic pathways by distinct alpha v integrins. , 1995, Science.
[42] P. Carvey,et al. 6‐Hydroxydopamine‐induced alterations in blood–brain barrier permeability , 2005, The European journal of neuroscience.
[43] D. Cheresh,et al. Integrin α v β 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels , 1994, Cell.
[44] H. Dvorak,et al. Vascular permeability, vascular hyperpermeability and angiogenesis , 2008, Angiogenesis.
[45] J. Newcombe,et al. Increased blood vessel density and endothelial cell proliferation in multiple sclerosis cerebral white matter , 2010, Neuroscience Letters.
[46] P S Whitton,et al. Inflammation as a causative factor in the aetiology of Parkinson's disease , 2007, British journal of pharmacology.
[47] David A. Cheresh,et al. Definition of Two Angiogenic Pathways by Distinct αv Integrins , 1995, Science.
[48] S. Rocha,et al. Regulation of gene expression by hypoxia. , 2008, The Biochemical journal.
[49] E. Hirsch,et al. Blood vessels and parkinsonism. , 2004, Frontiers in bioscience : a journal and virtual library.
[50] P. Carvey,et al. The blood–brain barrier in neurodegenerative disease: a rhetorical perspective , 2009, Journal of neurochemistry.
[51] J. Folkman. Endogenous angiogenesis inhibitors , 2004, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[52] Rakesh K Jain,et al. Antiangiogenic therapy for cancer: current and emerging concepts. , 2005, Oncology.
[53] P. Grammas,et al. Angiogenic proteins are expressed by brain blood vessels in Alzheimer's disease. , 2006, Journal of Alzheimer's disease : JAD.
[54] M. Cenci,et al. Differential Involvement of D1 and D2 Dopamine Receptors in L-DOPA-Induced Angiogenic Activity in a Rat Model of Parkinson's Disease , 2009, Neuropsychopharmacology.
[55] D. McDonald,et al. Regulated angiogenesis and vascular regression in mice overexpressing vascular endothelial growth factor in airways. , 2004, The American journal of pathology.
[56] J. Geiger,et al. Caffeine protects against MPTP‐induced blood‐brain barrier dysfunction in mouse striatum , 2008, Journal of neurochemistry.
[57] F. Fadda,et al. Role of striatal l‐DOPA in the production of dyskinesia in 6‐hydroxydopamine lesioned rats , 2006, Journal of neurochemistry.
[58] E. Hirsch,et al. Changes in vascularization in substantia nigra pars compacta of monkeys rendered parkinsonian , 2005, Journal of Neural Transmission.
[59] D. Dickson,et al. Incidental Lewy body disease and preclinical Parkinson disease. , 2008, Archives of neurology.
[60] A. Drzezga,et al. In vivo characterization of endothelial cell activation in a transgenic mouse model of Alzheimer’s disease , 2006, Angiogenesis.
[61] D. Paik,et al. Ongoing angiogenesis in blood vessels of the abdominal aortic aneurysm , 2004, Experimental & Molecular Medicine.
[62] D. Cheresh,et al. Requirement of vascular integrin alpha v beta 3 for angiogenesis. , 1994, Science.
[63] S. Leurgans,et al. The neuropathology of probable Alzheimer disease and mild cognitive impairment , 2009, Annals of neurology.
[64] E. Hirsch,et al. Blood vessels change in the mesencephalon of patients with Parkinson's disease , 1999, The Lancet.
[65] Hansjürgen Bratzke,et al. Stages in the development of Parkinson’s disease-related pathology , 2004, Cell and Tissue Research.
[66] J. Frank,et al. Angiogenesis in multiple sclerosis: is it good, bad or an epiphenomenon? , 2004, Journal of the Neurological Sciences.
[67] D. Bennett,et al. The neuropathology of older persons with and without dementia from community versus clinic cohorts. , 2009, Journal of Alzheimer's disease : JAD.
[68] H. Braak,et al. Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen , 2003, Journal of Neural Transmission.
[69] B. Jenkins,et al. The blood–brain barrier is intact after levodopa-induced dyskinesias in parkinsonian primates—Evidence from in vivo neuroimaging studies , 2009, Neurobiology of Disease.
[70] S. Leurgans,et al. Neurodegenerative basis of age-related cognitive decline , 2010, Neurology.
[71] Rakesh K Jain,et al. Molecular regulation of vessel maturation , 2003, Nature Medicine.
[72] C. ffrench-Constant,et al. Expression of αvβ3 and αvβ8 integrins during oligodendrocyte precursor differentiation in the presence and absence of axons , 1997, Glia.
[73] W. Lukiw,et al. Angiogenic signaling in Alzheimer's disease , 2004, Neuroreport.
[74] H. Braak,et al. Reply to “Controversies over the staging of α-synuclein pathology in Parkinson’s disease” , 2008, Acta Neuropathologica.
[75] H. Gendelman,et al. Regulatory T Cells Attenuate Th17 Cell-Mediated Nigrostriatal Dopaminergic Neurodegeneration in a Model of Parkinson’s Disease , 2010, The Journal of Immunology.
[76] P. Lantos,et al. Progressive supranuclear palsy (PSP): a quantitative study of the pathological changes in cortical and subcortical regions of eight cases , 2007, Journal of Neural Transmission.
[77] D. Dickson,et al. Evidence that incidental Lewy body disease is pre-symptomatic Parkinson’s disease , 2008, Acta Neuropathologica.
[78] D. McDonald,et al. Markers for Microscopic Imaging of Lymphangiogenesis and Angiogenesis , 2008, Annals of the New York Academy of Sciences.
[79] S. Karlik,et al. VEGF and angiogenesis in acute and chronic MOG(35–55) peptide induced EAE , 2009, Journal of Neuroimmunology.
[80] P. Brooks,et al. Role of integrins in angiogenesis. , 1996, European journal of cancer.
[81] D. Hanahan,et al. Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis , 1996, Cell.
[82] P. Mcgeer,et al. Reactive microglia are positive for HLA‐DR in the substantia nigra of Parkinson's and Alzheimer's disease brains , 1988, Neurology.